Unipol Assicurazioni

Where we land

Unipol is an Italian insurer whose business is mostly non-life cover: the kind of policy that pays out for a crashed car, a flooded warehouse or a business interruption, rather than for a pension or a savings plan. Four years ago its yearly net profit was 454m; today it is 1.8bn. Yet its shares are priced as if profits will shrink steadily from here.

We think that gloom underrates the insurer. Selling and pricing non-life cover in Italy has done the heavy lifting, and the price gives it no credit for that. A growing stake in an Italian bank runs alongside and carries real uncertainty, but our view holds whatever that holding brings, because the insurance engine on its own looks better than the price allows. We award Unipol gold.

What the business is

Commercial insurance, where motor, property and business cover sit, makes up 76% of revenue. Life and health insurance, covering savings-style life policies and medical cover, makes up 19%. The remaining 5% comes from non-insurance holdings that behave more like a portfolio of private investments than an insurance operation.

The mix has moved. In July 2023 commercial insurance was 69% of sales; since then its sales have grown 38%, while life and health sales have fallen 21%, sliding from 30% of the group. Unipol has become more of a non-life insurer and less of a savings house, not through any single decision but through one side growing as the other contracted. That matters: more of the group now rests on short-term policies repriced every year, and less on long-term savings products whose economics are set for years at a time.

After claims and running costs, Unipol keeps an operating margin of 13%, meaning roughly 13 of every 100 of revenue is left as operating profit: respectable for an insurer, though not the best in its peer group.

Why now

What has put Unipol in the spotlight is a decision about capital. In August it set out a target of holding more than 30% of the banking group that would come from combining BPER and Monte dei Paschi, building on an earlier project to acquire Monte dei Paschi branches. That would take Unipol from investor in and partner of a bank to anchor shareholder of one of the country's larger banks.

The ambition arrives with the underlying business in strong shape. On quality, meaning how reliably it turns capital into profit, Unipol is among the strongest companies we rate, and it is priced in line with cheaper insurers elsewhere. It joined our Gold Income 10 this month, with one of the sturdiest dividends in the list.

The case for

Start with the profits. Between 2023 and 2025 operating profit held in a band of roughly 1.1bn to 1.3bn a year. In the twelve months to June 2026 it reached 2.0bn, up from 1.3bn a year earlier, and net profit climbed to 1.8bn from 1.2bn. That is a clear change of level, not a gentle drift.

The returns behind it are solid. Return on equity, the profit earned on each unit of shareholders' money tied up in the business, stands at 15.3%. Unipol's quality standing sits in the upper quarter of the market and has edged higher over the past year, suggesting the improvement runs through more than a single line of the accounts.

Growth has been steady too. Group sales have risen 7.9% a year over three years and 6.9% in the latest year, concentrated in non-life insurance while life and health shrank, so the business is being reshaped by its mix and not just its volume.

Where the growth could come from

The live story is the bank stake. With analysts expecting only about 3% growth in earnings per share next year, the question is whether this use of capital, alongside the non-life engine, can do better. The holding would not appear as a revenue line; bank stakes show up as investment income and dividends, and our figures do not show how much they contribute today. It could bring a share of bank profits that might be large relative to Unipol's own earnings, and a much larger branch network through which to sell insurance to bank customers. Against that, it ties up capital and brings regulatory and deal risk.

The established engine is the non-life book in Italy, where most of the profit comes from. The economics are simple to state and hard to execute: an insurer collects premiums today and pays claims later, and makes money when its price rises keep ahead of the rising cost of repairs, parts and settlements. With sales here growing about 7% a year, whether claims costs keep pace with prices decides whether earnings beat the modest forecast. Success would show as a stable or improving combined ratio, the share of premiums eaten up by claims and running costs.

A quieter support comes from interest rates. The European Central Bank has raised its deposit rate to 2.50%, and the euro-area 10-year government yield has risen 0.67 points over a year to 3.37%. For an insurer holding large bond portfolios against its policies, that most likely means reinvesting maturing bonds at higher returns, lifting the margin on savings products and on money held back for future non-life claims. That fits the improvement in profits, though it is our reading rather than something reported. The catch is that rising yields also cut the value of bonds already held, which can weigh on the solvency ratio, the measure of capital cover regulators watch, or tempt savers to withdraw.

Health insurance is another possible source. Much private health cover in Italy is sold through employer welfare schemes, where Unipol's UniSalute is a leading player. Our figures do not split health from life within its 19% of revenue, but the likely picture is a faster-growing, less cyclical stream of premiums that would reduce the group's dependence on the motor pricing cycle. Health premiums outgrowing the group, and new large employer contracts, would show it.

The businesses beyond insurance, such as long-term car rental, telematics and hotels, most likely make up the 5% private-investment line and are too small to move group earnings today. Their value is as an option: rental and telematics could deepen ties with motor customers and support pricing, or the units could be sold to free capital for the bank stake or for dividends.

The case against

First, the valuation is less obviously cheap once margins are counted. Unipol trades at 11 times earnings, alongside Travelers at 10 times and MS&AD and Sompo at 9, though well below Tokio Marine at 21. Its 13.3% operating margin beats Zurich and Tokio Marine but falls well short of Chubb, Travelers and MS&AD, which run at 22-24%. Investors can reasonably argue that a lower-margin insurer deserves a lower price, and that Unipol is valued about where it should be.

Second, the step up may be the peak. Analysts expect earnings per share to move from 2.10 to only 2.16 next year, growth of about 2.9%: those who follow the company most closely see a new plateau rather than the start of a climb. Both forecast changes in the last 45 days were upward, which softens the point without overturning it.

Third, insurance profits swing hard, and Unipol's have: in the year to June 2022 operating profit roughly halved to 555m before recovering. A bad run of claims, a sharp rise in repair costs or a weather event could undo much of the latest year's gain, and a business this exposed to motor and property cover in a single country has limited places to hide.

What the price assumes

One way to read a share price is to ask what it would have to believe for the shares to be fairly valued. Suppose the price stayed flat for five years and the shares were then valued at 18.5 times earnings, the middle of the range for every profitable listed company we cover. For that to hold, Unipol's earnings would need to shrink by 11% a year for five years, taking earnings per share down to 1.36.

Against that, operating profit has grown 27% a year over the past three years. If that trend simply continued, earnings per share would reach 7.84 in five years, 574% of what the price requires. We are not suggesting it will; the latest year's jump makes a repeat unlikely. But the gap between a business that has been compounding and a price that assumes it will contract is wide enough that even a sharp slowdown would leave the price looking too cautious.

The market has started to notice: the shares are up 33% over the past year and 13% over the past six months. Yet the price still embeds a shrinking business.

The other side of the medal

The risk we would watch most closely is the bank. Unipol is placing a growing bet whose payoff is not yet measurable: it hinges on a merger between BPER and Monte dei Paschi that still has to be agreed and approved. Until it is, the capital committed is working on a promise.

This risk matters most because it is the one most able to change what Unipol is. Our case rests on a strong, well-run non-life insurer that the market underrates. A controlling-size stake in a large bank would make Unipol's results depend in part on lending, bank regulation and the success of a complex combination, none of which its insurance skill can influence. If the deal stalls, or is approved on terms that absorb capital without lifting returns, the cost would fall on the very earnings that make the shares look cheap.

What to watch

First, the bank: whether the BPER and Monte dei Paschi combination is agreed and approved, and whether Unipol's holding is confirmed above 30%. Approval is a hard event that resolves much of the uncertainty either way; delays or conditions imposed on the deal, a holding below the target, or capital diverted from dividends without a clear return would be the warning signs. After that, the earlier signal of real value is whether the enlarged branch network starts selling Unipol's insurance, because new policies through bank branches would show up before any meaningful bank earnings do.

Second, the gap between motor premiums and claim costs. Renewal price rises and the cost of repairs and settlements move ahead of reported profits, so a gap widening in Unipol's favour is the earliest sign the non-life engine can beat the modest forecast; a narrowing one would warn that the latest year's profits are under pressure. Alongside it, a rising average yield on the investment portfolio with a steady solvency ratio would confirm that rising euro yields are helping rather than hurting.

Our reading would be wrong if the jump to 2.0bn in operating profit proves a one-off and earnings slip back toward the 1.2bn to 1.3bn level of 2024 and 2025, or if the push for a stake above 30% absorbs capital without lifting returns. Either outcome would mean the market's caution was justified after all.

The numbers

The same industry, for comparison

Research for information, not personal investment advice or a recommendation to buy, sell or hold any security: see Important information. Data as at 31 October 2026.